CINGULATE INC.(CING)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CING CINGULATE INC.

交易中 04-14 15:47:11 EDT

5.39

-0.11

-2.00%

最高5.71	最低5.32	成交量48.14万
今开5.55	昨收5.50	日振幅7.09%
总市值6,268万	流通市值5,779万	总股本1,163万
成交额263.34万	换手率4.49%	流通股本1,072万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CING","market":"US","secType":"STK","nameCN":"CINGULATE INC.","latestPrice":5.39,"timestamp":1776196011342,"preClose":5.5,"halted":0,"volume":481412,"delay":0,"changeRate":-0.02000000000000006,"floatShares":10722500,"shares":11628613,"eps":-4.44084,"marketStatus":"交易中","change":-0.11,"latestTime":"04-14 15:47:11 EDT","open":5.55,"high":5.7099,"low":5.32,"amount":2633385.0681712,"amplitude":0.070891,"askPrice":5.42,"askSize":310,"bidPrice":5.36,"bidSize":400,"shortable":3,"etf":0,"ttmEps":-4.44084,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1776196800000},"marketStatusCode":2,"adr":0,"listingDate":1633579200000,"exchange":"NASDAQ","adjPreClose":5.5,"preHourTrading":{"tag":"盘前","latestPrice":5.6,"preClose":5.5,"latestTime":"09:25 EDT","volume":1737,"amount":9679.583619,"timestamp":1776173109738,"change":0.1,"changeRate":0.018182,"amplitude":0.025455},"postHourTrading":{"tag":"盘后","latestPrice":5.49,"preClose":5.5,"latestTime":"19:38 EDT","volume":7109,"amount":38985.4289,"timestamp":1776123511335,"change":-0.01,"changeRate":-0.001818,"amplitude":0.009091},"volumeRatio":1.343184},"requestUrl":"/m/hq/s/CING","defaultTab":"news","newsList":[{"id":"1164062833","title":"Cingulate Inc提交招股说明书补充文件，拟分阶段发行并出售最高1亿美元普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1164062833","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164062833?lang=zh_cn&edition=full","pubTime":"2026-03-25 05:21","pubTimestamp":1774387304,"startTime":"0","endTime":"0","summary":"Cingulate Inc已向美国证券交易委员会提交招股说明书补充文件，计划通过市场发行方式，分阶段出售总额最高达1亿美元的普通股。此次股票发行将根据市场状况和公司资金需求灵活进行，所得资金拟用于推进其核心候选药物的临床试验及一般企业用途。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CING"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116356752","title":"CINGULATE INC.提交文件：林肯公园资本基金拟发售及转售最多350万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1116356752","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116356752?lang=zh_cn&edition=full","pubTime":"2026-03-20 18:05","pubTimestamp":1774001102,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）最新披露的文件，生物制药公司CINGULATE INC.已提交相关申请，其机构投资者林肯公园资本基金（Lincoln Park Capital Fund）计划发售及转售最多350万股公司普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CING"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613776968","title":"Cingulate Inc.盘中异动 股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613776968","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613776968?lang=zh_cn&edition=full","pubTime":"2026-02-24 02:12","pubTimestamp":1771870341,"startTime":"0","endTime":"0","summary":"北京时间2026年02月24日02时12分，Cingulate Inc.股票出现波动，股价快速拉升5.09%。截至发稿，该股报6.19美元/股，成交量21.4202万股，换手率2.88%，振幅7.47%。Cingulate Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Cingulate Inc.公司简介：Cingulate Inc是一家临床阶段的生物制药公司，利用其专有的精准定时释放药物递送平台来建立和推进下一代药物产品管线，旨在改善那些因每日繁琐的给药方案和治疗效果不佳而痛苦的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224021221a716a0e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224021221a716a0e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CING","ADHD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160297260","title":"Cingulate完成1200万美元纳斯达克规则下按市价定价的私募配售","url":"https://stock-news.laohu8.com/highlight/detail?id=1160297260","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160297260?lang=zh_cn&edition=full","pubTime":"2026-02-17 21:01","pubTimestamp":1771333306,"startTime":"0","endTime":"0","summary":"生物制药公司Cingulate Inc.今日宣布，已成功完成一笔总金额达1200万美元的私募股权配售。此次融资严格遵循纳斯达克市场规则，采用按市价定价机制执行。该笔资金将主要用于推进公司核心候选药物的临床研发进程，并强化企业运营资本储备。\n本次私募发行吸引了专业机构投资者的积极参与，反映出市场对Cingulate创新技术平台及研发管线的认可。公司管理层表示，此次融资将为关键临床试验的开展提供重要资金支持，加速精准定时给药技术的商业化布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CING","CINGW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610622674","title":"Cingulate Inc.盘中异动 临近午盘股价大跌5.19%报7.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610622674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610622674?lang=zh_cn&edition=full","pubTime":"2026-02-10 00:46","pubTimestamp":1770655588,"startTime":"0","endTime":"0","summary":"北京时间2026年02月10日00时46分，Cingulate Inc.股票出现异动，股价大幅下挫5.19%。截至发稿，该股报7.30美元/股，成交量25.2921万股，换手率3.40%，振幅7.92%。Cingulate Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Cingulate Inc.公司简介：Cingulate Inc是一家临床阶段的生物制药公司，利用其专有的精准定时释放药物递送平台来建立和推进下一代药物产品管线，旨在改善那些因每日繁琐的给药方案和治疗效果不佳而痛苦的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021000462897a586bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021000462897a586bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CING","ADHD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606736660","title":"Cingulate Inc.盘中异动 早盘大幅上涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606736660","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606736660?lang=zh_cn&edition=full","pubTime":"2026-01-27 22:31","pubTimestamp":1769524308,"startTime":"0","endTime":"0","summary":"北京时间2026年01月27日22时31分，Cingulate Inc.股票出现波动，股价快速上涨5.16%。截至发稿，该股报5.30美元/股，成交量6483股，换手率0.09%，振幅0.40%。Cingulate Inc.股票所在的生物技术行业中，整体涨幅为0.58%。Cingulate Inc.公司简介：Cingulate Inc是一家临床阶段的生物制药公司，利用其专有的精准定时释放药物递送平台来建立和推进下一代药物产品管线，旨在改善那些因每日繁琐的给药方案和治疗效果不佳而痛苦的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127223149953e9780&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127223149953e9780&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ADHD","CING"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605235183","title":"Cingulate Inc.盘中异动 早盘股价大跌5.40%报5.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605235183","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605235183?lang=zh_cn&edition=full","pubTime":"2026-01-23 23:45","pubTimestamp":1769183131,"startTime":"0","endTime":"0","summary":"北京时间2026年01月23日23时45分，Cingulate Inc.股票出现波动，股价快速跳水5.40%。截至发稿，该股报5.08美元/股，成交量9.1749万股，换手率1.23%，振幅5.77%。Cingulate Inc.股票所在的生物技术行业中，整体跌幅为0.33%。Cingulate Inc.公司简介：Cingulate Inc是一家临床阶段的生物制药公司，利用其专有的精准定时释放药物递送平台来建立和推进下一代药物产品管线，旨在改善那些因每日繁琐的给药方案和治疗效果不佳而痛苦的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012323453197a32ac9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012323453197a32ac9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CING","ADHD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604949388","title":"Cingulate Inc.盘中异动 股价大涨5.15%报5.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604949388","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604949388?lang=zh_cn&edition=full","pubTime":"2026-01-17 04:07","pubTimestamp":1768594036,"startTime":"0","endTime":"0","summary":"北京时间2026年01月17日04时07分，Cingulate Inc.股票出现波动，股价快速拉升5.15%。截至发稿，该股报5.72美元/股，成交量17.4522万股，换手率2.34%，振幅6.96%。Cingulate Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Cingulate Inc.公司简介：Cingulate Inc是一家临床阶段的生物制药公司，利用其专有的精准定时释放药物递送平台来建立和推进下一代药物产品管线，旨在改善那些因每日繁琐的给药方案和治疗效果不佳而痛苦的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117040716a72416a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117040716a72416a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CING","ADHD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601366654","title":"Cingulate Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601366654","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601366654?lang=zh_cn&edition=full","pubTime":"2026-01-08 04:07","pubTimestamp":1767816456,"startTime":"0","endTime":"0","summary":"北京时间2026年01月08日04时07分，Cingulate Inc.股票出现异动，股价大幅上涨5.00%。截至发稿，该股报4.91美元/股，成交量10.4537万股，换手率1.46%，振幅6.52%。Cingulate Inc.股票所在的生物技术行业中，整体涨幅为2.78%。Cingulate Inc.公司简介：Cingulate Inc是一家临床阶段的生物制药公司，利用其专有的精准定时释放药物递送平台来建立和推进下一代药物产品管线，旨在改善那些因每日繁琐的给药方案和治疗效果不佳而痛苦的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010804073697a135bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010804073697a135bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADHD","BK4007","CING"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123286747","title":"Cingulate Inc: John Roberts不再担任执行主席，但将继续担任董事会主席","url":"https://stock-news.laohu8.com/highlight/detail?id=1123286747","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123286747?lang=zh_cn&edition=full","pubTime":"2025-12-15 22:18","pubTimestamp":1765808301,"startTime":"0","endTime":"0","summary":"Cingulate Inc: John Roberts不再担任执行主席，但将继续担任董事会主席","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CING"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2585173297","title":"Cingulate Inc.盘中异动 下午盘快速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585173297","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585173297?lang=zh_cn&edition=full","pubTime":"2025-11-22 03:06","pubTimestamp":1763751993,"startTime":"0","endTime":"0","summary":"北京时间2025年11月22日03时06分，Cingulate Inc.股票出现异动，股价大幅拉升5.03%。截至发稿，该股报3.63美元/股，成交量4.8577万股，换手率0.72%，振幅6.36%。Cingulate Inc.股票所在的生物技术行业中，整体涨幅为1.28%。Cingulate Inc.公司简介：Cingulate Inc是一家临床阶段的生物制药公司，利用其专有的精准定时释放药物递送平台来建立和推进下一代药物产品管线，旨在改善那些因每日繁琐的给药方案和治疗效果不佳而痛苦的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122030633a4b233d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122030633a4b233d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CING","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583068766","title":"Cingulate Inc.盘中异动 股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583068766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583068766?lang=zh_cn&edition=full","pubTime":"2025-11-14 22:57","pubTimestamp":1763132266,"startTime":"0","endTime":"0","summary":"北京时间2025年11月14日22时57分，Cingulate Inc.股票出现波动，股价快速拉升5.11%。截至发稿，该股报3.50美元/股，成交量8.6336万股，换手率1.54%，振幅6.61%。Cingulate Inc.股票所在的生物技术行业中，整体涨幅为0.65%。Cingulate Inc.公司简介：Cingulate Inc是一家临床阶段的生物制药公司，利用其专有的精准定时释放药物递送平台来建立和推进下一代药物产品管线，旨在改善那些因每日繁琐的给药方案和治疗效果不佳而痛苦的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114225746a4a1e5c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114225746a4a1e5c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CING"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198776848","title":"Cingulate公布Ctx-1301积极的第三阶段结果，显示出显著的疗效和全天候症状控制","url":"https://stock-news.laohu8.com/highlight/detail?id=1198776848","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198776848?lang=zh_cn&edition=full","pubTime":"2025-10-28 20:01","pubTimestamp":1761652910,"startTime":"0","endTime":"0","summary":"Cingulate公布Ctx-1301积极的第三阶段结果，显示出显著的疗效和全天候症状控制","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CING","CINGW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2575226518","title":"Cingulate Inc.盘中异动 急速下跌5.68%报3.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575226518","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575226518?lang=zh_cn&edition=full","pubTime":"2025-10-14 22:45","pubTimestamp":1760453139,"startTime":"0","endTime":"0","summary":"北京时间2025年10月14日22时45分，Cingulate Inc.股票出现波动，股价急速跳水5.68%。截至发稿，该股报3.82美元/股，成交量17.9095万股，换手率3.19%，振幅7.88%。Cingulate Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Cingulate Inc.公司简介：Cingulate Inc是一家临床阶段的生物制药公司，利用其专有的精准定时释放药物递送平台来建立和推进下一代药物产品管线，旨在改善那些因每日繁琐的给药方案和治疗效果不佳而痛苦的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014224540a45fc8df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014224540a45fc8df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CING"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143498844","title":"FDA接受Cingulate公司CTX-1301治疗注意力缺陷多动障碍(ADHD)的新药申请，并设定2026年5月31日为PDUFA日期","url":"https://stock-news.laohu8.com/highlight/detail?id=1143498844","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143498844?lang=zh_cn&edition=full","pubTime":"2025-10-14 20:04","pubTimestamp":1760443473,"startTime":"0","endTime":"0","summary":"FDA接受Cingulate公司CTX-1301治疗注意力缺陷多动障碍(ADHD)的新药申请，并设定2026年5月31日为PDUFA日期","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CING","CINGW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517910048","title":"Cingulate Inc.盘中异动 股价大跌5.18%报3.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517910048?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185087,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分，Cingulate Inc.股票出现异动，股价快速下跌5.18%。截至发稿，该股报3.65美元/股，成交量1.5788万股，换手率0.49%，振幅3.12%。Cingulate Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Cingulate Inc.公司简介：Cingulate Inc 是一家临床阶段的生物制药公司，利用其专有的精确定时释放给药平台来构建和推进下一代药物产品的管道，旨在改善患有频繁诊断疾病的患者的生活，这些疾病的特点是繁琐的每日给药方案和治疗结果欠佳。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223127abe9b08d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223127abe9b08d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CING"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516663996","title":"Cingulate Inc.盘中异动 临近收盘大幅下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516663996","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516663996?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:44","pubTimestamp":1741034655,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时44分，Cingulate Inc.股票出现异动，股价大幅下挫5.07%。截至发稿，该股报3.91美元/股，成交量8.2184万股，换手率2.56%，振幅5.58%。Cingulate Inc.股票所在的生物技术行业中，整体跌幅为0.24%。Cingulate Inc.公司简介：Cingulate Inc 是一家临床阶段的生物制药公司，利用其专有的精确定时释放给药平台来构建和推进下一代药物产品的管道，旨在改善患有频繁诊断疾病的患者的生活，这些疾病的特点是繁琐的每日给药方案和治疗结果欠佳。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304044415abe69a5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304044415abe69a5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CING"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514373812","title":"Cingulate Inc.盘中异动 早盘大幅下挫5.21%报4.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514373812","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514373812?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:51","pubTimestamp":1740754268,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时51分，Cingulate Inc.股票出现波动，股价急速下跌5.21%。截至发稿，该股报4.00美元/股，成交量3.0594万股，换手率0.95%，振幅2.49%。Cingulate Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Cingulate Inc.公司简介：Cingulate Inc 是一家临床阶段的生物制药公司，利用其专有的精确定时释放给药平台来构建和推进下一代药物产品的管道，旨在改善患有频繁诊断疾病的患者的生活，这些疾病的特点是繁琐的每日给药方案和治疗结果欠佳。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822510896341eb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822510896341eb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CING"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514168210","title":"Cingulate Inc.盘中异动 快速跳水5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514168210","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514168210?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:33","pubTimestamp":1740497627,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时33分，Cingulate Inc.股票出现异动，股价快速跳水5.26%。截至发稿，该股报3.96美元/股，成交量5.2281万股，换手率1.63%，振幅5.26%。Cingulate Inc.股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为1075.69%、596.43%、562.36%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为64.05%、61.16%、60.87%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233347a25395f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233347a25395f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CING","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512055488","title":"Cingulate Inc.盘中异动 早盘股价大涨6.02%报4.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512055488","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512055488?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:32","pubTimestamp":1739975546,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时32分，Cingulate Inc.股票出现波动，股价大幅上涨6.02%。截至发稿，该股报4.58美元/股，成交量1.2204万股，换手率0.38%，振幅3.20%。Cingulate Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Osr Holdings, Inc.、Aditxt, Inc.、Citius Pharmaceuticals, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Chemomab Therapeutics Ltd较为活跃，换手率分别为212.30%、203.38%、65.72%，振幅较大的相关个股有Osr Holdings, Inc.、Azitra Inc、Opthea Limited，振幅分别为33.76%、11.29%、11.01%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192232269628cd63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192232269628cd63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CING"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cingulate.com","stockEarnings":[{"period":"1week","weight":-0.1129},{"period":"1month","weight":-0.3671},{"period":"3month","weight":0.1179},{"period":"6month","weight":0.375},{"period":"1year","weight":0.4474},{"period":"ytd","weight":0.2673}],"compareEarnings":[{"period":"1week","weight":0.0412},{"period":"1month","weight":0.036},{"period":"3month","weight":-0.0111},{"period":"6month","weight":0.0315},{"period":"1year","weight":0.285},{"period":"ytd","weight":0.0061}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cingulate Inc.于2012年12月14日在特拉华州成立。该公司是一家生物制药公司，利用其专有的精准定时释放药物递送平台，为注意缺陷多动障碍和焦虑症开发下一代产品。其主要候选药物CTx-1301和CTx-1302旨在作为每日一次的多动症兴奋剂药物，同时也在开发CTx-2103，一种每日一次的丁螺环酮制剂，用于治疗焦虑症。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.143656},{"month":2,"riseRate":0.4,"avgChangeRate":0.01358},{"month":3,"riseRate":0.4,"avgChangeRate":-0.044027},{"month":4,"riseRate":0.2,"avgChangeRate":-0.076541},{"month":5,"riseRate":0,"avgChangeRate":-0.197282},{"month":6,"riseRate":0.75,"avgChangeRate":-0.035954},{"month":7,"riseRate":0.5,"avgChangeRate":-0.055289},{"month":8,"riseRate":0.75,"avgChangeRate":0.301563},{"month":9,"riseRate":0.25,"avgChangeRate":-0.156522},{"month":10,"riseRate":0.25,"avgChangeRate":-0.153936},{"month":11,"riseRate":0.25,"avgChangeRate":-0.072096},{"month":12,"riseRate":1,"avgChangeRate":0.130431}],"exchange":"NASDAQ","name":"CINGULATE INC.","nameEN":"CINGULATE INC."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CINGULATE INC.(CING)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CINGULATE INC.(CING)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CINGULATE INC.,CING,CINGULATE INC.股票,CINGULATE INC.股票老虎,CINGULATE INC.股票老虎国际,CINGULATE INC.行情,CINGULATE INC.股票行情,CINGULATE INC.股价,CINGULATE INC.股市,CINGULATE INC.股票价格,CINGULATE INC.股票交易,CINGULATE INC.股票购买,CINGULATE INC.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CINGULATE INC.(CING)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CINGULATE INC.(CING)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}